Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.
We present the first direct evidence that adverse effects, particularly severe destructive arthritis, can develop in vaccinated hamsters after challenge with Borrelia burgdorferi sensu lato isolates. Hamsters were vaccinated with a whole-cell preparation of Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 in adjuvant. A severe destructive arthritis was readily evoked in vaccinated hamsters challenged with the homologous B. burgdorferi sensu stricto isolate C-1-11 before high levels of protective borreliacidal antibody developed. Once high levels of C-1-11 borreliacidal antibody developed, hamsters were protected from homologous challenge and development of arthritis. Vaccinated hamsters, however, still developed severe destructive arthritis when challenged with other isolates of the three genomic groups of B. burgdorferi sensu lato (B. burgdorferi sensu stricto isolate 297, Borrelia garinii isolate LV4, and Borrelia afzelii isolate BV1) despite high levels of C-1-11 specific borreliacidal antibody. Vaccines that contained whole spirochetes in adjuvant induced destructive arthritis, but this effect was not dependent on the isolate of B. burgdorferi sensu lato or the type of adjuvant. These studies demonstrate that caution is necessary when employing whole spirochetes in adjuvant for vaccination to prevent Lyme borreliosis. Additional studies are needed to identify the antigen(s) responsible for the induction and activation of arthritis and to define the immune mechanisms involved.
Lim
L C
LC
Wisconsin State Laboratory of Hygiene, Madison 53706.
England
D M
DM
DuChateau
B K
BK
Glowacki
N J
NJ
Creson
J R
JR
Lovrich
S D
SD
Callister
S M
SM
Jobe
D A
DA
Schell
R F
RF
D000276:Adjuvants, Immunologic; D000818:Animals; D017849:Animals, Inbred Strains; D000907:Antibodies, Bacterial / Q000097:blood; D001168:Arthritis / Q000209:etiology*; D001522:Behavior, Animal; D006224:Cricetinae; D006614:Hindlimb / Q000473:pathology; D008193:Lyme Disease / Q000150:complications* / Q000517:prevention & control*; D009068:Movement; D013045:Species Specificity; D014611:Vaccination / Q000009:adverse effects*
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial